Breaking News Bar

Business News and Information

Merck to Hold Fourth-Quarter 2009 Sales and Earnings Conference Call on Feb. 16

Merck & Co., Inc. (NYSE: MRK) will hold its fourth-quarter 2009 sales and earnings conference call with institutional investors and analysts beginning at 8 a.m. EST on Tuesday, Feb. 16. During the call, Richard T. Clark, chairman, president and chief executive officer, Peter N. Kellogg, executive vice president and chief financial officer, and Kenneth C. Frazier, executive vice president and president, Global Human Health, will provide an overview of Merck’s financial performance for the quarter as well as year-end results.

Journalists are invited to listen-only by calling (706) 758-9928 or (800) 399-7917. At the conclusion of the call, journalists who wish to ask questions are invited to call Media Relations. A replay of the call will be available starting at 11 a.m. EST on Feb. 16 through 5 p.m. EST on Feb. 23. To listen to the replay, dial (706) 645-9291 or (800) 642-1687 and enter ID No. 49426477.

Investors, journalists and the general public may access a live audio webcast of the call on Merck’s Web site at Software needed to listen to the webcast is available on the corporate web site and should be downloaded prior to the beginning of the webcast. A replay of the webcast will be available from 11 a.m. EST on Feb. 16 through 5 p.m. EST on Feb. 23. The fourth-quarter sales and earnings press release and supplemental financial disclosures also will be available in the Newsroom.

About Merck

Today's Merck is working to help the world be well. Through our medicines, vaccines, biologic therapies, and consumer and animal products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching programs that donate and deliver our products to the people who need them. Merck. Be Well. For more information, visit


Merck & Co., Inc.
David Caouette, 908-423-3461
Amy Rose, 908-423-6537
Alex Kelly, 908-423-5185

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear